Dynavax Technologies reported $1.64B in Market Capitalization this July of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 286.33B 46.96B
Adma Biologics ADMA:US $ 0.36B 0.08B
Agenus AGEN:US $ 0.64B 0.19B
Amgen AMGN:US $ 129.08B 2.36B
AstraZeneca AZN:LN 156.99B 22.53B
Astrazeneca AZN:US 206.18B 24.27B
Biogen BIIB:US $ 30.95B 4.29B
Biomarin Pharmaceutical BMRN:US $ 14.26B 1.96B
Bristol Myers Squibb BMY:US $ 155.49B 17.09B
Chimerix CMRX:US $ 0.4B 0.16B
Dynavax Technologies DVAX:US $ 1.35B 0.33B
Gilead Sciences GILD:US $ 74.66B 16.42B
Glaxosmithkline GSK:US 109.98B 0.61B
Idera Pharmaceuticals IDRA:US $ 0.03B 0B
Merk MRK:US $ 207.45B 13.86B
Minerva Neurosciences NERV:US $ 0.04B 0B
Nektar Therapeutics NKTR:US $ 1B 1.49B
Neurocrine Biosciences NBIX:US $ 8.95B 0.87B
Novartis NOVN:VX 197.8B 2.36B
Pfizer PFE:US $ 292.38B 39.06B
Regeneron Pharmaceuticals REGN:US $ 75.81B 7.89B
Roche Holding ROG:VX 300.5B 1.25B
Sarepta Therapeutics SRPT:US $ 6.81B 1.03B
Tg Therapeutics TGTX:US $ 1.36B 1.36B
Vertex Pharmaceuticals VRTX:US $ 66.69B 10.85B